(ENSG) The Ensign - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US29358P1012

ENSG: Skilled Nursing, Senior Living, Rehabilitative Services

The Ensign Group, Inc. (NASDAQ:ENSG) operates as a prominent healthcare provider specializing in skilled nursing, senior living, and rehabilitative services. The company is structured into two primary segments: Skilled Services and Standard Bearer. The Skilled Services segment offers comprehensive care, including short-term and long-term nursing for patients with chronic conditions and the elderly, along with specialized services such as on-site dialysis, ventilator care, and cardiac management. Additionally, this segment provides essential services including accommodations, nutritional programs, social activities, and recreational entertainment. The Standard Bearer segment focuses on leasing post-acute care facilities to healthcare operators, diversifying the companys revenue streams. Ensign also provides ancillary services like digital x-rays, ultrasounds, and pharmacy services, enhancing their holistic care approach. With operations across multiple U.S. states, the company has established a strong presence in the post-acute care sector, likely through strategic expansions and acquisitions. Headquartered in San Juan Capistrano, California, Ensign was incorporated in 1999 and has grown to become a key player in the healthcare industry.

Based on technical and fundamental analysis, the three-month forecast for ENSG indicates a potential rebound despite current bearish trends. Technically, the stocks price is below its 20, 50, and 200-day SMAs, suggesting short-term weakness. The Average True Range (ATR) of 3.88 indicates moderate volatility, signaling possible price fluctuations. However, fundamentally, the companys healthy return on equity (RoE) of 16.19% and a forward P/E of 20.49 suggest expected earnings growth, which may offset the current downturn. The price-to-book (P/B) ratio of 4.01 reflects market confidence in growth prospects. Considering these factors, ENSG is expected to trade within a range of $120 to $130 over the next quarter, balancing near-term challenges with longer-term growth potential.

Additional Sources for ENSG Stock

ENSG Stock Overview

Market Cap in USD 7,858m
Sector Healthcare
Industry Medical Care Facilities
GiC Sub-Industry Health Care Facilities
IPO / Inception 2007-11-09

ENSG Stock Ratings

Growth Rating 74.9
Fundamental 72.7
Dividend Rating 50.0
Rel. Strength 35.2
Analysts 4.4/5
Fair Price Momentum 161.97 USD
Fair Price DCF 79.24 USD

ENSG Dividends

Dividend Yield 12m 0.17%
Yield on Cost 5y 0.60%
Annual Growth 5y 3.68%
Payout Consistency 98.6%

ENSG Growth Ratios

Growth Correlation 3m 15.4%
Growth Correlation 12m -1.6%
Growth Correlation 5y 91.8%
CAGR 5y 28.73%
CAGR/Max DD 5y 1.03
Sharpe Ratio 12m 0.88
Alpha 17.34
Beta 0.131
Volatility 28.14%
Current Volume 1259.7k
Average Volume 20d 419.9k
What is the price of ENSG stocks?
As of May 15, 2025, the stock is trading at USD 144.79 with a total of 1,259,744 shares traded.
Over the past week, the price has changed by +5.73%, over one month by +11.43%, over three months by +13.16% and over the past year by +22.79%.
Is The Ensign a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, The Ensign (NASDAQ:ENSG) is currently (May 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 72.66 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ENSG as of May 2025 is 161.97. This means that ENSG is currently undervalued and has a potential upside of +11.87% (Margin of Safety).
Is ENSG a buy, sell or hold?
The Ensign has received a consensus analysts rating of 4.40. Therefor, it is recommend to buy ENSG.
  • Strong Buy: 3
  • Buy: 1
  • Hold: 1
  • Sell: 0
  • Strong Sell: 0
What are the forecast for ENSG stock price target?
According to ValueRays Forecast Model, ENSG The Ensign will be worth about 175.4 in May 2026. The stock is currently trading at 144.79. This means that the stock has a potential upside of +21.12%.
Issuer Forecast Upside
Wallstreet Target Price 166.2 14.8%
Analysts Target Price 166.2 14.8%
ValueRay Target Price 175.4 21.1%